United States · FDA National Drug Code directory
Quetiapine Fumarate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50742-637_57efb2c4-97c7-4f4b-8e1f-e73ec6d6c176
- Product NDC
- 50742-637
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- quetiapine fumarate
- Labeler
- Ingenus Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170831
- Source listing expiry
- 20261231
Source-listed ingredients
- QUETIAPINE FUMARATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-637-10) · 50742-637-10
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-637-30) · 50742-637-30
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-637-60) · 50742-637-60
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-637-90) · 50742-637-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →